Get started
NOVARTIS INC NOVARTIS INC NOVARTIS INC

NOVARTIS INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

NOT chart


Full chart

NOT upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪184.41 B‬ EUR
Dividend yield (indicated)
3.81%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
8.09 EUR
Net income (FY)
‪14.36 B‬ EUR
Revenue (FY)
‪43.94 B‬ EUR
Shares float
‪1.75 B‬
Beta (1Y)
0.83

Employees


Employees (FY)
‪76.06 K‬
Change (1Y)
‪−25.65 K‬ −25.22%
Revenue / Employee (1Y)
‪577.76 K‬ EUR
Net income / Employee (1Y)
‪108.94 K‬ EUR

About NOVARTIS N


Sector
Health Technology
CEO
Vasant Narasimhan
Headquarters
Basel
Website
novartis.com
Founded
1996
ISIN
CH0012005267
FIGI
BBG000P33R75
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

NOT news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

NOT highest yielding bonds


N
US66989HAS7
NOVARTIS CAP 20/50
Yield to maturity
6.68%
Maturity date
Aug 14, 2050
N
XPND
NOVARTIS CAPITAL 15/45
Yield to maturity
5.90%
Maturity date
Nov 20, 2045
N
US66989HAH1
NOVARTIS CAPITAL 14/44
Yield to maturity
5.72%
Maturity date
May 6, 2044
N
NVS5894401
Novartis Capital Corp. 4.7% 18-SEP-2054
Yield to maturity
5.72%
Maturity date
Sep 18, 2054
N
NVS3904288
Novartis Capital Corp. 3.7% 21-SEP-2042
Yield to maturity
5.65%
Maturity date
Sep 21, 2042
N
NVS5894400
Novartis Capital Corp. 4.2% 18-SEP-2034
Yield to maturity
5.25%
Maturity date
Sep 18, 2034
N
US66989HAR9
NOVARTIS CAP 20/30
Yield to maturity
5.13%
Maturity date
Aug 14, 2030
N
NVS5894399
Novartis Capital Corp. 4.0% 18-SEP-2031
Yield to maturity
4.88%
Maturity date
Sep 18, 2031
N
NVS5894398
Novartis Capital Corp. 3.8% 18-SEP-2029
Yield to maturity
4.78%
Maturity date
Sep 18, 2029
N
XPNC
NOVARTIS CAPITAL 15/25
Yield to maturity
4.64%
Maturity date
Nov 20, 2025
N
US66989HAN8
NOVARTIS CAPITAL 17/27
Yield to maturity
4.61%
Maturity date
May 17, 2027

Explore more bonds 

Sparks


Curated watchlists where NOT is featured.

See all sparks 

Frequently Asked Questions


The current price of NOT is 95.97 EUR — it has decreased by −3.68% in the past 24 hours. Watch NOVARTIS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange NOVARTIS INC stocks are traded under the ticker NOT.
We've gathered analysts' opinions on NOVARTIS INC future price: according to them, NOT price has a max estimate of 132.55 EUR and a min estimate of 89.84 EUR. Watch NOT chart and read a more detailed NOVARTIS INC stock forecast: see what analysts think of NOVARTIS INC and suggest that you do with its stocks.
NOT reached its all-time high on Jan 29, 2024 with the price of 100.58 EUR, and its all-time low was 26.44 EUR and was reached on Mar 4, 2009. View more price dynamics on NOT chart.
See other stocks reaching their highest and lowest prices.
NOT stock is 5.81% volatile and has beta coefficient of 0.83. Track NOVARTIS INC stock price on the chart and check out the list of the most volatile stocks — is NOVARTIS INC there?
Today NOVARTIS INC has the market capitalization of ‪182.15 B‬, it has decreased by −0.51% over the last week.
Yes, you can track NOVARTIS INC financials in yearly and quarterly reports right on TradingView.
NOVARTIS INC is going to release the next earnings report on Jan 31, 2025. Keep track of upcoming events with our Earnings Calendar.
NOT earnings for the last quarter are 1.85 EUR per share, whereas the estimation was 1.74 EUR resulting in a 6.27% surprise. The estimated earnings for the next quarter are 1.76 EUR per share. See more details about NOVARTIS INC earnings.
NOVARTIS INC revenue for the last quarter amounts to ‪11.52 B‬ EUR, despite the estimated figure of ‪11.49 B‬ EUR. In the next quarter, revenue is expected to reach ‪12.53 B‬ EUR.
NOT net income for the last quarter is ‪2.93 B‬ EUR, while the quarter before that showed ‪3.05 B‬ EUR of net income which accounts for −3.95% change. Track more NOVARTIS INC financial stats to get the full picture.
Yes, NOT dividends are paid annually. The last dividend per share was 3.43 EUR. As of today, Dividend Yield (TTM)% is 3.81%. Tracking NOVARTIS INC dividends might help you take more informed decisions.
NOVARTIS INC dividend yield was 3.89% in 2023, and payout ratio reached 51.36%. The year before the numbers were 3.83% and 105.08% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has ‪76.06 K‬ employees. See our rating of the largest employees — is NOVARTIS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVARTIS INC EBITDA is ‪19.10 B‬ EUR, and current EBITDA margin is 44.33%. See more stats in NOVARTIS INC financial statements.
Like other stocks, NOT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVARTIS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVARTIS INC technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVARTIS INC stock shows the strong buy signal. See more of NOVARTIS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.